Epitope-targeting platform for broadly protective influenza vaccines.
Seasonal influenza vaccines are often ineffective because they elicit strain-specific antibody responses to mutation-prone sites on the hemagglutinin (HA) head. Vaccines that provide long-lasting immunity to conserved epitopes are needed. Recently, we reported a nanoparticle-based vaccine platform p...
Guardado en:
Autores principales: | David F Zeigler, Emily Gage, Christopher H Clegg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8ef46c113354e9abff9adbbc0fb7f49 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A naturally protective epitope of limited variability as an influenza vaccine target
por: Craig P. Thompson, et al.
Publicado: (2018) -
A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection
por: Yansheng Li, et al.
Publicado: (2021) -
Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.
por: Byoung-Shik Shim, et al.
Publicado: (2011) -
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.
por: Penghui Yang, et al.
Publicado: (2012) -
Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
por: Mariana Baz, et al.
Publicado: (2015)